Acadia Pharmaceuticals | Capital Ordinaire



Ordinary Share Capital Changement Date
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Corcept Therapeutics USD 105.29M 105.15M 2025-06
Cytokinetics USD 119.6M 119.48M 2025-06
Eisai JPY 282.12M 44.7B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Incyte USD 194.12M 193.93M 2025-06
J&J USD 3.12B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Prothena USD 538K 0 2024-12
PTC Therapeutics USD 79.38M 79.3M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Acadia Pharmaceuticals Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.